|Isolation of multipotent cells from human term placenta|
BL Yen, HI Huang, CC Chien, HY Jui, BS Ko, M Yao, CT Shun, M Yen, ...
Stem cells 23 (1), 3-9, 2005
|AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations|
JL Tang, HA Hou, CY Chen, CY Liu, WC Chou, MH Tseng, CF Huang, ...
Blood, The Journal of the American Society of Hematology 114 (26), 5352-5361, 2009
|Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking|
DM Huang, Y Hung, BS Ko, SC Hsu, WH Chen, CL Chien, CP Tsai, ...
The FASEB journal 19 (14), 2014-2016, 2005
|TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics|
WC Chou, SC Chou, CY Liu, CY Chen, HA Hou, YY Kuo, MC Lee, BS Ko, ...
Blood, The Journal of the American Society of Hematology 118 (14), 3803-3810, 2011
|The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles|
DM Huang, JK Hsiao, YC Chen, LY Chien, M Yao, YK Chen, BS Ko, ...
Biomaterials 30 (22), 3645-3651, 2009
|DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications|
HA Hou, YY Kuo, CY Liu, WC Chou, MC Lee, CY Chen, LI Lin, MH Tseng, ...
Blood, The Journal of the American Society of Hematology 119 (2), 559-568, 2012
|Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations|
WC Chou, HH Huang, HA Hou, CY Chen, JL Tang, M Yao, W Tsay, BS Ko, ...
Blood, The Journal of the American Society of Hematology 116 (20), 4086-4094, 2010
|The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells|
YC Chen, JK Hsiao, HM Liu, IY Lai, M Yao, SC Hsu, BS Ko, YC Chen, ...
Toxicology and applied pharmacology 245 (2), 272-279, 2010
|WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system|
HA Hou, TC Huang, LI Lin, CY Liu, CY Chen, WC Chou, JL Tang, ...
Blood, The Journal of the American Society of Hematology 115 (25), 5222-5231, 2010
|The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia|
WC Chou, WC Lei, BS Ko, HA Hou, CY Chen, JL Tang, M Yao, W Tsay, ...
Leukemia 25 (2), 246-253, 2011
|RUNX1 gene mutation in primary myelodysplastic syndrome – the mutation can be detected early at diagnosis or acquired during disease progression and is …|
CY Chen, LI Lin, JL Tang, BS Ko, W Tsay, WC Chou, M Yao, SJ Wu, ...
British journal of haematology 139 (3), 405-414, 2007
|The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution|
SJ Wu, YY Kuo, HA Hou, LY Li, MH Tseng, CF Huang, FY Lee, MC Liu, ...
Blood, The Journal of the American Society of Hematology 120 (15), 3106-3111, 2012
|TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution|
HA Hou, WC Chou, YY Kuo, CY Liu, LI Lin, MH Tseng, YC Chiang, ...
Blood cancer journal 5 (7), e331-e331, 2015
|Genetic alterations and their clinical implications in older patients with acute myeloid leukemia|
CH Tsai, HA Hou, JL Tang, CY Liu, CC Lin, WC Chou, MH Tseng, ...
Leukemia 30 (7), 1485-1492, 2016
|IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease …|
CC Lin, HA Hou, WC Chou, YY Kuo, CY Liu, CY Chen, YJ Lai, MH Tseng, ...
American journal of hematology 89 (2), 137-144, 2014
|Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia|
HA Hou, CC Lin, WC Chou, CY Liu, CY Chen, JL Tang, YJ Lai, MH Tseng, ...
Leukemia 28 (1), 50-58, 2014
|Cyclooxygenase-2-Derived Prostaglandin E2 Protects Mouse Embryonic Stem Cells from Apoptosis|
JY Liou, DP Ellent, S Lee, J Goldsby, BS Ko, N Matijevic, JC Huang, ...
Stem Cells 25 (5), 1096-1103, 2007
|Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome|
TC Chen, HA Hou, WC Chou, JL Tang, YY Kuo, CY Chen, MH Tseng, ...
Blood cancer journal 4 (1), e177-e177, 2014
|Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia–the occurrence of retinoic acid syndrome is a risk factor|
BS Ko, JL Tang, YC Chen, M Yao, CH Wang, MC Shen, HF Tien
Leukemia 13 (9), 1406-1408, 1999
|Acute myeloid leukemia bearing t (7; 11)(p15; p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients|
WC Chou, CY Chen, HA Hou, LI Lin, JL Tang, M Yao, W Tsay, BS Ko, ...
Leukemia 23 (7), 1303-1310, 2009